20 May 2020 - Data show responses in 73% of patients who were treated with Rozlytrek. ...
5 May 2020 - Venclexta (venetoclax) plus obinutuzumab is the first chemotherapy-free, fixed-duration combination regimen approved by Health Canada for patients ...
28 April 2020 - Data show more than half of trial patients across all 10 tumour types studied had responses to ...
16 April 2020 - Breast cancer is the most common female cancer in Canada. ...
7 April 2020 - Netspot is the first and only kit for the preparation of gallium (68 Ga) oxodotreotide injection for ...
1 March 2020 - Prescription drug negotiations steeped in secrecy, leaving taxpayers in the dark on costs. ...
24 February 2020 - Diagnostic testing is available to identify which patients are most likely to benefit from BALVERSA, offering a ...
23 January 2020 - Approval based on results of KEYNOTE-426, Where Keytruda in combination with axitinib reduced the risk of death ...
14 January 2020 - Xospata is the first and only targeted treatment approved by Health Canada for patients with relapsed or ...
8 January 2020 - Calquence (acalabrutinib) is now available for adult patients with previously untreated and relapsed/refractory chronic lymphocytic leukaemia. ...
16 December 2019 - Janssen announced today that Health Canada, following a priority review, has approved Erleada (apalutamide) for the ...
12 December 2019 - Ontario government to reimburse Kymriah therapy for certain patients with life-threatening cancers who are in critical need. ...
6 December 2019 - Health Canada also provides an update on approvals of new drugs and medical devices for Canadians. ...
25 November 2019 - Approval of supplemental new drug aubmission for Adcetris in combination with CHP chemotherapy in frontline CD30-expressing peripheral ...
21 November 2019 - New indication improves overall survival for end stage metastatic disease ...